Compare AGNC Investment Corp (AGNC) vs McKesson Corporation (MCK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AGNC Investment Corp vs McKesson Corporation — how do they compare? AGNC Investment Corp trades at $10.95 (market cap $12.76B), while McKesson Corporation trades at $817.75 (market cap $94.52B). The key difference: McKesson Corporation is far larger — about 7.4× AGNC Investment Corp's market cap, and AGNC Investment Corp pays the higher dividend (12.95%). Which is the better fit depends on your goals.
| AGNC | MCK | |
|---|---|---|
Market Cap | $12.76B | $94.52B |
Sector | Financials | Health |
52-Week High | $12.17 | $995.69 |
52-Week Low | $9.20 | $659.01 |
Dividend Yield | 12.95% | 0.41% |
Enterprise Value | — | $99.16B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AGNC Investment Corp
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.
Read more on AGNC →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
